Back to Results
First PageMeta Content



Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664
Add to Reading List

Document Date: 2017-06-02 05:25:57


Open Document

File Size: 478,76 KB

Share Result on Facebook
UPDATE